Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L1UA
|
||||
Former ID |
DNC009645
|
||||
Drug Name |
N-(4-hydroxybenzyl)icosa-5,8,11,14-tetraenamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529838] | ||
Structure |
Download2D MOL |
||||
Formula |
C27H39NO2
|
||||
Canonical SMILES |
CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCC1=CC=C(C=C1)O
|
||||
InChI |
1S/C27H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-27(30)28-24-25-20-22-26(29)23-21-25/h6-7,9-10,12-13,15-16,20-23,29H,2-5,8,11,14,17-19,24H2,1H3,(H,28,30)/b7-6-,10-9-,13-12-,16-15-
|
||||
InChIKey |
YSOGPKZWDUJRGP-DOFZRALJSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529838] | |
Cannabinoid receptor 1 | Target Info | Inhibitor | [529838] | ||
Cannabinoid receptor 2 | Target Info | Inhibitor | [529838] | ||
BioCyc Pathway | Anandamide degradation | ||||
PANTHER Pathway | Anandamide degradationP05730:Endogenous cannabinoid signaling | ||||
Pathway Interaction Database | N-cadherin signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.